
Join to view full profile
A Blue Dot, LLCBuilding 300, Suite201McLean, VA 22101
Dr. Escolar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Diana Escolar, based in McLean, VA, specializes in neurology with subspecialties in neuromuscular medicine and neurophysiology. She completed her medical education at the University of Buenos Aires and pursued residency in neurology at Boston University Medical Center. Her fellowship training included pediatric neuromuscular/electromyography at Children's Hospital and neuromuscular medicine at Lahey Clinic. Dr. Escolar has served as a Chief Medical Officer at several companies and has held faculty positions at Kennedy Krieger Institute, Johns Hopkins University, and Children's National Hospital. She has expertise in electromyography, clinical research, and both neuromuscular and pediatric neuromuscular medicine. Her research has been published extensively, including studies on Cobomarsen and Pompe disease, with her work cited numerous times. She has also led several clinical trials related to therapies for neuromuscular and other related conditions.
Education & Training
Childrens HospitalFellowship, Pediatric Neuromuscular/ Electromyography (Lahey Clinic Program), 1992 - 1993
Lahey ClinicFellowship, Neuromuscular Medicine (Neurology), 1992 - 1993
Boston University Medical CenterResidency, Neurology, 1989 - 1992
Waltham Weston Hospital Medical CenterInternship, Transitional Year, 1988 - 1989
University of Buenos AiresClass of 1987
Certifications & Licensure
MD State Medical License 2010 - 2026
VA State Medical License 2023 - 2026
DC State Medical License 1993 - 2013
American Board of Psychiatry and Neurology Neurology
Clinical Trials
Publications & Presentations
PubMed
- 107 citationsCobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo.Eleni Anastasiadou, Anita G. Seto, Xuan Beatty, Melanie Hermreck, Maud-Emmanuelle Gilles
Clinical Cancer Research. 2021-02-15 - 37 citationsBarriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders.Holly L. Peay, Barbara B. Biesecker, Benjamin S. Wilfond, Jill Jarecki, Kendall L. Umstead
Clinical Trials. 2018-02-23 - 178 citationsMyostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trialCraig Campbell, Hugh J. McMillan, Jean K. Mah, Mark A. Tarnopolsky, Kathryn Selby
Muscle & Nerve. 2017-04-01
Press Mentions
Chutes & Ladders—GSK Vaccine Exec Reichman Splits to Take Biotech CEO PostJanuary 22nd, 2021
Diem Nguyen Tapped to Lead 'Point of Inflection' at Xalud Therapeutics; Diana Escolar Dances Her Way to Avrobio CMOJanuary 22nd, 2021- miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, IncOctober 28th, 2020
Grant Support
- Human Clinical CoreEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2009
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









